Dr. Mitchell Miglis, MD

NPI: 1972779411
Total Payments
$39,101
2024 Payments
$5,963
Companies
8
Transactions
64
Medicare Patients
1,826
Medicare Billing
$174,486

Payment Breakdown by Category

Consulting$19,670 (50.3%)
Other$12,740 (32.6%)
Food & Beverage$3,454 (8.8%)
Travel$2,877 (7.4%)
Gifts$359.98 (0.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $19,670 8 50.3%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,240 1 23.6%
Honoraria $3,500 1 9.0%
Food and Beverage $3,454 38 8.8%
Travel and Lodging $2,877 15 7.4%
Gift $359.98 1 0.9%

Top Paying Companies

Company Total Records Latest Year
JAZZ PHARMACEUTICALS INC. $27,698 30 $0 (2024)
Lundbeck LLC $9,368 15 $0 (2018)
ARGENX US, INC. $696.14 12 $0 (2023)
PFIZER INC. $550.00 1 $0 (2022)
NeuroMetrix Inc $359.98 1 $0 (2017)
HARMONY BIOSCIENCES LLC $220.98 3 $0 (2024)
Medtronic USA, Inc. $167.85 1 $0 (2017)
Alnylam Pharmaceuticals Inc. $40.61 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $5,963 7 JAZZ PHARMACEUTICALS INC. ($5,915)
2023 $14,603 29 Jazz Pharmaceuticals Inc. ($13,774)
2022 $8,598 10 JAZZ PHARMACEUTICALS INC. ($7,968)
2019 $41.39 1 JAZZ PHARMACEUTICALS INC. ($41.39)
2018 $4,747 7 Lundbeck LLC ($4,747)
2017 $5,149 10 Lundbeck LLC ($4,621)

All Payment Transactions

64 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
09/18/2024 JAZZ PHARMACEUTICALS INC. XYWAV (Drug) Consulting Fee Cash or cash equivalent $2,680.00 General
Category: NEUROLOGY
09/17/2024 JAZZ PHARMACEUTICALS INC. Consulting Fee Cash or cash equivalent $2,680.00 General
08/21/2024 JAZZ PHARMACEUTICALS INC. Food and Beverage In-kind items and services $122.20 General
08/20/2024 JAZZ PHARMACEUTICALS INC. XYWAV (Drug) Food and Beverage In-kind items and services $149.79 General
Category: NEUROLOGY
04/25/2024 JAZZ PHARMACEUTICALS INC. XYWAV (Drug) Food and Beverage In-kind items and services $142.08 General
Category: NEUROLOGY
02/16/2024 HARMONY BIOSCIENCES LLC WAKIX (Drug) Food and Beverage Cash or cash equivalent $48.10 General
Category: Narcoplepsy
02/08/2024 JAZZ PHARMACEUTICALS INC. XYWAV (Drug) Food and Beverage In-kind items and services $140.43 General
Category: NEUROLOGY
12/13/2023 Jazz Pharmaceuticals Inc. XYWAV (Drug) Food and Beverage In-kind items and services $139.85 General
Category: NEUROLOGY
11/16/2023 Alnylam Pharmaceuticals Inc. AMVUTTRA (Drug) Food and Beverage In-kind items and services $40.61 General
Category: Genetic Disease
09/20/2023 Jazz Pharmaceuticals Inc. XYWAV (Drug) Food and Beverage In-kind items and services $146.46 General
Category: NEUROLOGY
09/11/2023 Jazz Pharmaceuticals Inc. XYWAV (Drug) Travel and Lodging Cash or cash equivalent $104.92 General
Category: NEUROLOGY
09/11/2023 Jazz Pharmaceuticals Inc. XYWAV (Drug) Food and Beverage In-kind items and services $28.88 General
Category: NEUROLOGY
09/05/2023 Jazz Pharmaceuticals Inc. XYWAV (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $9,240.00 General
Category: NEUROLOGY
08/25/2023 Jazz Pharmaceuticals Inc. XYWAV (Drug) Food and Beverage In-kind items and services $74.67 General
Category: NEUROLOGY
08/25/2023 Jazz Pharmaceuticals Inc. XYWAV (Drug) Food and Beverage In-kind items and services $49.69 General
Category: NEUROLOGY
08/25/2023 Jazz Pharmaceuticals Inc. XYWAV (Drug) Travel and Lodging Cash or cash equivalent $32.48 General
Category: NEUROLOGY
08/25/2023 Jazz Pharmaceuticals Inc. XYWAV (Drug) Food and Beverage In-kind items and services $24.44 General
Category: NEUROLOGY
08/25/2023 Jazz Pharmaceuticals Inc. XYWAV (Drug) Food and Beverage In-kind items and services $11.45 General
Category: NEUROLOGY
08/24/2023 Jazz Pharmaceuticals Inc. XYWAV (Drug) Travel and Lodging Cash or cash equivalent $427.81 General
Category: NEUROLOGY
08/24/2023 Jazz Pharmaceuticals Inc. XYWAV (Drug) Travel and Lodging Cash or cash equivalent $348.37 General
Category: NEUROLOGY
07/18/2023 Jazz Pharmaceuticals Inc. XYWAV (Drug) Food and Beverage In-kind items and services $145.34 General
Category: NEUROLOGY
04/19/2023 Jazz Pharmaceuticals Inc. XYWAV (Drug) Food and Beverage In-kind items and services $150.00 General
Category: NEUROLOGY
04/12/2023 Harmony Biosciences LLC WAKIX (Drug) Food and Beverage Cash or cash equivalent $92.14 General
Category: SLEEP MEDICINE
03/03/2023 Jazz Pharmaceuticals Inc. XYWAV (Drug) Consulting Fee Cash or cash equivalent $2,850.00 General
Category: NEUROLOGY
02/01/2023 ARGENX US, INC. VYVGART (Drug) Travel and Lodging In-kind items and services $224.87 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 481 549 $362,798 $44,964
2022 13 481 548 $345,647 $45,457
2021 9 419 472 $295,141 $41,140
2020 9 445 508 $282,184 $42,925
Total Patients
1,826
Total Services
2,077
Medicare Billing
$174,486
Procedure Codes
54

All Medicare Procedures & Services

54 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 114 142 $97,188 $11,510 11.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 75 103 $59,406 $8,383 14.1%
95924 Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt Facility 2023 64 64 $32,754 $4,863 14.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 32 37 $22,746 $4,849 21.3%
95810 Sleep study in sleep lab (6 years or older) Office 2023 29 29 $44,268 $3,104 7.0%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 19 24 $17,473 $2,766 15.8%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 15 15 $15,083 $2,338 15.5%
95923 Testing of autonomic (sympathetic) nervous system function Facility 2023 55 55 $16,546 $2,158 13.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 24 25 $14,085 $1,278 9.1%
95811 Sleep study in sleep lab with continuous airway pressure (6 years or older) Office 2023 11 11 $18,602 $1,225 6.6%
95808 Sleep study in sleep lab Office 2023 12 13 $11,862 $980.98 8.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 11 11 $6,445 $774.84 12.0%
95800 Sleep study including heart rate, breathing, and sleep time Office 2023 20 20 $6,340 $734.20 11.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 102 120 $85,448 $9,424 11.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 65 98 $57,208 $7,865 13.7%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 42 52 $36,772 $6,152 16.7%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 30 30 $30,120 $4,559 15.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 29 30 $23,478 $3,466 14.8%
95924 Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt Facility 2022 38 38 $15,462 $3,059 19.8%
95811 Sleep study in sleep lab with continuous airway pressure (6 years or older) Office 2022 17 17 $21,920 $1,893 8.6%
95923 Testing of autonomic (sympathetic) nervous system function Facility 2022 34 34 $7,506 $1,423 19.0%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2022 11 11 $8,002 $1,362 17.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 20 21 $10,983 $1,201 10.9%
95808 Sleep study in sleep lab Office 2022 14 14 $10,703 $1,124 10.5%
95810 Sleep study in sleep lab (6 years or older) Office 2022 11 11 $13,558 $1,112 8.2%

About Dr. Mitchell Miglis, MD

Dr. Mitchell Miglis, MD is a Neurology healthcare provider based in Stanford, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2008. The National Provider Identifier (NPI) number assigned to this provider is 1972779411.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitchell Miglis, MD has received a total of $39,101 in payments from pharmaceutical and medical device companies, with $5,963 received in 2024. These payments were reported across 64 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($19,670).

As a Medicare-enrolled provider, Miglis has provided services to 1,826 Medicare beneficiaries, totaling 2,077 services with total Medicare billing of $174,486. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Other Specialties Sleep Medicine, Clinical Neurophysiology
  • Location Stanford, CA
  • Active Since 05/05/2008
  • Last Updated 11/10/2023
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • NPI Number 1972779411

Products in Payments

  • XYWAV (Drug) $20,030
  • NORTHERA (Drug) $9,368
  • SUNOSI (Drug) $4,560
  • VYVGART (Drug) $696.14
  • Quell (Device) $359.98
  • ACTIVA (Device) $167.85
  • WAKIX (Drug) $140.24
  • Wakix (Drug) $80.74
  • XYREM (Drug) $41.39
  • AMVUTTRA (Drug) $40.61

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Stanford